Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2005 1
2006 2
2007 1
2008 2
2010 4
2011 4
2013 3
2014 3
2015 2
2017 1
2020 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Asymptomatic and mild primary hyperparathyroidism.
Macfarlane DP, Yu N, Leese GP. Macfarlane DP, et al. Ann Endocrinol (Paris). 2015 May;76(2):120-7. doi: 10.1016/j.ando.2015.03.001. Epub 2015 Apr 14. Ann Endocrinol (Paris). 2015. PMID: 25882891 Review.
Oral antidiabetic agents as cardiovascular drugs.
Macfarlane DP, Paterson KR, Fisher M. Macfarlane DP, et al. Diabetes Obes Metab. 2007 Jan;9(1):23-30. doi: 10.1111/j.1463-1326.2006.00592.x. Diabetes Obes Metab. 2007. PMID: 17199715 Review.
The utility of retinal screening in gestational diabetes.
Macfarlane DP, O'Sullivan EP, Dorman S, Allison J, Ellingford A, Pearson ER, Mires GJ, Leese GP. Macfarlane DP, et al. Diabet Med. 2013 Aug;30(8):1009-10. doi: 10.1111/dme.12152. Diabet Med. 2013. PMID: 23398520 No abstract available.
5α-reductase type 1 modulates insulin sensitivity in men.
Upreti R, Hughes KA, Livingstone DE, Gray CD, Minns FC, Macfarlane DP, Marshall I, Stewart LH, Walker BR, Andrew R. Upreti R, et al. Among authors: macfarlane dp. J Clin Endocrinol Metab. 2014 Aug;99(8):E1397-406. doi: 10.1210/jc.2014-1395. Epub 2014 May 13. J Clin Endocrinol Metab. 2014. PMID: 24823464 Free PMC article. Clinical Trial.
22 results